Harel Insurance Investments & Financial Services’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-347
| Closed | -$15K | – | 587 |
|
|
2024
Q1 | $15K | Sell |
347
-50
| -13% | -$2.16K | ﹤0.01% | 462 |
|
|
2023
Q4 | $17K | Sell |
397
-167
| -30% | -$7.15K | ﹤0.01% | 512 |
|
|
2023
Q3 | $21K | Sell |
564
-120
| -18% | -$4.47K | ﹤0.01% | 546 |
|
|
2023
Q2 | $26K | Sell |
684
-500
| -42% | -$19K | ﹤0.01% | 551 |
|
|
2023
Q1 | $29K | Buy |
1,184
+501
| +73% | +$12.3K | ﹤0.01% | 559 |
|
|
2022
Q4 | $20K | Sell |
683
-50
| -7% | -$1.46K | ﹤0.01% | 572 |
|
|
2022
Q3 | $21K | Sell |
733
-49
| -6% | -$1.4K | ﹤0.01% | 595 |
|
|
2022
Q2 | $28K | Sell |
782
-45
| -5% | -$1.61K | ﹤0.01% | 605 |
|
|
2022
Q1 | $36K | Sell |
827
-69
| -8% | -$3K | ﹤0.01% | 573 |
|
|
2021
Q4 | $45K | Buy |
+896
| New | +$45K | ﹤0.01% | 604 |
|